Kalaris Therapeutics Inc Stock Performance
as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
$4.5$4.91
2.81%
Downside
6.05%
Upside
52 Week's Low
52 Week's High
$2.14$12.953.78%
Downside
178.62%
Upside
Kalaris Therapeutics Inc share price movements today
- Previous Close
- $4.79
- Open
- $4.85
- Volume
- 193.8K
- Day's Low - High
- $4.5 - $4.91
- 52 Week Low - High
- $2.14 - $12.9
Kalaris Therapeutics Inc Historical Returns
- 1 Month Return
- + 5.47 %
- 3 Month Return
- + 93.72 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Kalaris Therapeutics Inc Stock Fundamentals & Key Indicators
Check Kalaris Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$45.3M
EPS (TTM)
-5.255
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
2316500.00%
Kalaris Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $45.3M | NA | NA | 0.00% | |
| BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
| NA | $36.7B | NA | NA | -3.89% | |
| BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
| BUY | $60.3B | -3.62% | 14.35 | 31.37% |
Kalaris Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Kalaris Therapeutics Inc Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Kalaris Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Kalaris Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Kalaris Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, KLRS stock has moved up by 93.7%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 136.8%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 246.2%
About Kalaris Therapeutics Inc
| Organisation | Kalaris Therapeutics Inc |
| Headquarters | 628 Middlefield Road, Palo Alto, CA, United States, 94301 |
| CEO | Mr. Andrew Oxtoby |
| E-voting on shares | Click here to vote |
Key Management of Kalaris Therapeutics Inc
Name | Title |
|---|---|
Dr. Matthew Feinsod M.D. | Chief Medical Officer |
Ms. Kristine Curtiss | Senior Vice President of Clinical |
Mr. Andrew Oxtoby | President, CEO & Director |
Dr. Srinivas Akkaraju M.D., Ph.D. | Director & Co-Founder |
Dr. Michael Philip Dybbs Ph.D. | Director & Co-Founder |
Dr. Napoleone Ferrara M.D. | Independent Director & Co-Founder |
Mr. Brett R. Hagen | Senior VP Finance, CAO & Principal Financial Officer |
FAQs
What is Kalaris Therapeutics Inc share price today?
Kalaris Therapeutics Inc share price today is $4.63 as on at the close of the market. Kalaris Therapeutics Inc share today touched a day high of $4.91 and a low of $4.5.
What is the 52 week high and 52 week low for Kalaris Therapeutics Inc share?
Kalaris Therapeutics Inc share touched a 52 week high of $12.9 on and a 52 week low of $2.14 on . Kalaris Therapeutics Inc stock price today i.e. is closed at $4.63,which is 64.11% down from its 52 week high and 116.36% up from its 52 week low.
What is Kalaris Therapeutics Inc's market capitalisation today?
Kalaris Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Kalaris Therapeutics Inc Stock (KLRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kalaris Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics Inc Shares that will get you 0.3240 shares as per Kalaris Therapeutics Inc share price of $4.63 per share as on October 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Kalaris Therapeutics Inc Stock (KLRS) from India?
Indian investors can start investing in Kalaris Therapeutics Inc (KLRS) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Kalaris Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalaris Therapeutics Inc share’s latest price of $4.63 as on October 18, 2025 at 1:29 am IST, you will get 2.1598 shares of Kalaris Therapeutics Inc. Learn more about
fractional shares .